Oncology Product Portfolio
Oncology-only · EU-GMP / WHO-GMP sourcing · NAFDAC & PCN aligned
General Checkups
Platinum agents and taxanes used in breast, colorectal, lung, ovarian and other solid tumours.
Antimetabolites & Other Cytotoxics
Key agents such as antimetabolites used in common combination regimens.
Platinum & Taxane Combinations
Support for guideline-driven regimens using carboplatin, cisplatin, oxaliplatin and taxanes.
Oral Oncology & Hormonal Therapy
Oral agents and endocrine therapies used in breast, prostate and other hormone-sensitive cancers.
Supportive & Ancillary Medicines
Products that support chemotherapy delivery and help reduce treatment interruptions (for example G-CSF).
Future Portfolio & Pipeline
Space for new oncology molecules and in-licensed portfolios as our partnerships grow.
Built Around Real Oncology Practice
Our portfolio is designed around regimens that Nigerian oncologists use every day. We focus on molecules that are widely used, clinically meaningful and realistically sustainable within local budgets.
Backbone chemotherapy agents for solid tumours
Oral therapies and endocrine agents
Supportive medicines that protect treatment continuity
Products sourced from EU-GMP / WHO-GMP manufacturers
NAFDAC-registered or in process, in line with regulations
Example Molecules
Our range includes widely used oncology molecules such as carboplatin, oxaliplatin, cisplatin, paclitaxel, docetaxel, capecitabine, tamoxifen, aromatase inhibitors and selected supportive agents like filgrastim.
Availability is subject to NAFDAC registration status and stock levels. For an up-to-date product list, please contact our team.
Core Chemotherapy Injectables
Our injectable portfolio focuses on widely used backbone regimens in solid tumours. Example molecules include:
-
Carboplatin
-
Oxaliplatin
-
Cisplatin
-
Paclitaxel
-
Docetaxel
This list is illustrative only and may change over time. Please contact us for a current list and strengths available.
Need a Detailed Product List?
Share your oncology formulary or specific molecules of interest, and we’ll confirm which products we can support today and which are in our future pipeline.
Information on this page is intended for healthcare professionals and business partners only. It does not replace clinical guidelines, national protocols or the judgement of treating physicians. Product availability is subject to NAFDAC registration status and stock levels.
Commercial Enquiries
For pricing, tender participation and supply agreements:
Phone: [insert]
Email: [insert]
Clinical & Pharmacy Teams
Head Office
MedicoreOne
1234 Divi St. #1000,
San Francisco, CA
Nigeria